Dr. Yifat Merbl completed her BS summa cum laude in Computational Biology at Bar Ilan University in 2003. She earned an MSc in Immunology at the Weizmann Institute in 2005 with Prof. Irun Cohen. She joined the first PhD program in Systems Biology at Harvard Medical School, completing her PhD there in 2010. She stayed on at Harvard as a postdoctoral fellow in the Kirschner lab until joining the Department of Immunology at the Weizmann Institute in 2014.
Merbl’s research is focused on biochemical immunology where she explores how post-translational modifications, such as ubiquitin, are involved in proteostasis control in cancer and immune regulation. In addition her lab is invested in generating novel immunoproteomics technologies aiming at transforming current capabilities in analyzing the proteomic landscape in health and disease.
Dr. Merbl is the recipient of numerous awards for her scholastic and academic excellence, including an ERC Starting Grant (2015), the Alon Scholarship (2015), the Gruber Foundation Young Scientist Award (2015), and the Israeli Centers of Excellence Young Investigator Award (2014). She is also listed as a co-inventor on several patent applications for her proteomics techniques.
Click here to view information about the lab.
« Go Back